Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
Colorcon
Dow
Johnson and Johnson

Last Updated: September 28, 2022

Investigational Drug Information for Telcagepant


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Telcagepant?

Telcagepant is an investigational drug.

There have been 11 clinical trials for Telcagepant. The most recent clinical trial was a Phase 3 trial, which was initiated on February 15th 2007.

The most common disease conditions in clinical trials are Migraine Disorders, Heart Diseases, and Vascular Diseases. The leading clinical trial sponsors are Merck Sharp & Dohme Corp. and [disabled in preview].

Recent Clinical Trials for Telcagepant
TitleSponsorPhase
Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)Merck Sharp & Dohme Corp.Phase 2/Phase 3
Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)Merck Sharp & Dohme Corp.Phase 1
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)Merck Sharp & Dohme Corp.Phase 2

See all Telcagepant clinical trials

Clinical Trial Summary for Telcagepant

Top disease conditions for Telcagepant
Top clinical trial sponsors for Telcagepant

See all Telcagepant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
Colorcon
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.